Pre-IPO Secondary · Frontier Neurotech
A Guatemala-based family office mandated Calkhan to source pre-IPO exposure to frontier neurotechnology. Early term sheets were rejected as too expensive; we identified a primary-equivalent secondary block held by an early shareholder seeking partial liquidity ahead of an extended lockup.
Originated through our late-stage venture relationships, structured via a single-asset SPV with administrative carry waived and priced 2% below indicative broker quotes. Documents signed in eleven business days.
Allocation closed at a $9.0B implied valuation in six weeks — compensated solely on close, at zero upfront cost to the client.
Venture · Frontier Aerospace
A co-investment was syndicating alongside a frontier-aerospace round, on a low-fee basis with full information rights and a multi-year hold. The family had no existing GP relationship and would not have seen the allocation through traditional channels.
We rebuilt the model independently, ran reference calls, and negotiated a side-letter granting a pro-rata follow-on right. Capital was called in tranches post-close under the family's counsel.
€2.0M committed at favourable economics, targeting a 10–50× outcome over three to four years.

Fine Art · Private Treaty
A collector family sought a museum-quality work by a blue-chip post-war Italian master to anchor its collection — with secure provenance, acquired discreetly and away from the public auction calendar.
Surfaced through our dealer network ahead of any consignment, with authentication verified against the artist's foundation archive and an independent condition report commissioned prior to transfer. We managed price, title and museum-grade logistics end-to-end.
Sourced and placed privately at €2.5M — approximately 10% inside the auction comparable, with fully documented provenance.

Begin
We take a small number of family-office mandates each quarter. Tell us what you're looking to access.